Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
04/2014
04/17/2014WO2014011753A3 Anthraquinone analogs and methods of making and using thereof
04/17/2014US20140107369 Compounds useful in the synthesis of benzamide compounds
04/17/2014US20140107194 Compounds for use in the treatment of immune related inflammatory disease
04/17/2014US20140107124 Novel prostamides for the treatment of glaucoma and related diseases
04/16/2014CN103724360A Pyridine (or benzene) thiazole compound shown and intermediate, preparation method and application thereof
04/16/2014CN103724221A Preparation methods of amide-type compound and intermediate thereof as well as intermediate thereof
04/16/2014CN102633720B New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid
04/16/2014CN102001963B Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
04/16/2014CN101993388B Dimerization cassaine alkaloids as well as preparation method, pharmaceutical compositions and applications of dimerization cassaine alkaloids
04/15/2014US8697194 Curable overcoat compositions
04/15/2014CA2730478C Prodrugs of methyl hydrogen fumarate
04/10/2014WO2014055440A1 Preparation of gga and derivatives thereof and their co-crystallization with urea or thiourea
04/10/2014WO2014053857A1 Protected succinates for enhancing mitochondrial atp-production
04/10/2014WO2014053774A1 14-hydroxyeicosanoic acid-based fatty acid amide, as an organogelling agent
04/10/2014US20140100374 Synthesis process, and crystalline form of 4- benzamide hydrochloride and pharmaceutical compositions containing it
04/09/2014CN102516113B Series of diphenyl oxide derivatives and use of diphenyl oxide derivatives in preparation of anti-tuberculosis drugs
04/03/2014WO2014051971A1 Process for producing mma and/or maa from acetone cyanohydrin and sulfuric acid
04/03/2014WO2014051057A1 Gelling agent
04/03/2014WO2014048547A1 Alpha hydroxy amides
04/03/2014US20140094613 Process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and intermediate thereof
04/03/2014US20140094464 Quinone compounds for treating ape1 mediated diseases
04/03/2014US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9)
04/02/2014CN103702977A Novel benzoic acid amide compound
04/02/2014CN102471238B Method for manufacturing spilanthol and intermediate manufacturing product therefor
04/01/2014US8686154 Compounds and compositions for delivering active agents
04/01/2014US8686045 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
04/01/2014CA2594098C Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
03/2014
03/27/2014US20140088158 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
03/26/2014CN103664682A Synthetic method for 2-formamide cyclohexanone
03/26/2014CN103664681A Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide
03/26/2014CN103664622A Monomers and intermediates of AB type hydroxyl modified high polymer and preparation methods of monomers and intermediates
03/26/2014CN102391147B Preparation and activity of aryl formyl amino cyclopropanecarboxylic acid
03/25/2014US8680153 Method for correcting a lipid imbalance in a subject
03/25/2014CA2360000C Target molecule attachment to surfaces
03/20/2014US20140081045 Metal plating compositions and methods
03/19/2014CN103641738A Fluorine-containing chelating agent and preparation method and application thereof
03/19/2014CN103641731A Method for producing phenylacetamide compound
03/19/2014CN103641709A Halogenalkylmethylenoxy-phenyl-substituted ketoenols
03/19/2014CN102827080B Novel synthetic method of ivabradine and novel intermediate product of ivabradine
03/19/2014CN102702014B Method for preparing atorvastatin calcium intermediate
03/19/2014CN102351730B Method for preparing ceramide from konjac fly powder
03/18/2014US8674135 Functionalized ionic liquids, and methods of use thereof
03/18/2014US8673982 Ceramide-analogous metabolites
03/18/2014US8673946 4-trimethylammonio-butyrates as CPT2 inhibitors
03/18/2014US8673889 BLT2-mediated disease, BLT2 binding agent and the compound
03/13/2014WO2014038963A1 Dendrimer scaffolds for pharmaceutical use
03/13/2014US20140072532 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/12/2014CN102675144B Jasmonate hormone analogs and preparation method and application thereof
03/12/2014CN102300841B Phenolic compound and recording material
03/11/2014CA2674780C Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
03/06/2014WO2014015235A3 3,5,n-trihydroxy-alkanamide and derivatives: method for making same and use thereof
03/06/2014US20140066510 Oat extracts: refining, compositions and methods of use
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/05/2014CN103613510A Simple method for dehalogenating alpha-halogenated compounds
03/05/2014CN103610669A Bis-(p-alkoxy benzene acrylketone) like glutathione-S-transferase potential inhibitor
03/04/2014US8664275 Crystalline form of Bimatoprost, preparation method and use thereof
03/04/2014CA2565188C Compounds and compositions for delivering active agents
02/2014
02/27/2014WO2013186153A3 Amidophenoxypropanolamines
02/27/2014US20140057985 Estrogen receptor ligands and methods of use thereof
02/27/2014US20140057953 Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
02/27/2014US20140057946 Estrogen receptor ligands and methods of use thereof
02/26/2014CN103601649A Novel compound
02/26/2014CN101514168B Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl) propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
02/25/2014US8658695 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
02/25/2014CA2628232C Resorbable phenolic polymers
02/20/2014WO2014027696A1 Orally administrable viridiofungin derivative having anti-hcv activity
02/20/2014US20140051762 Polycationic compounds and uses thereof
02/20/2014US20140051678 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
02/19/2014CN103588673A Cancer pain medicament
02/19/2014CN103588672A Drug for treating cancer pain
02/19/2014CN103588671A Medicine for treating cancer pain
02/19/2014CN103588670A Cancer pain medicine
02/19/2014CN103588669A Compound having activity of releasing cancer pain
02/19/2014CN103588668A 化合物 Compound
02/19/2014CN103588667A New compound
02/19/2014CN103588666A Compound with high optical purity
02/19/2014CN103588665A Compound for treatment of cancer pain
02/19/2014CN103588664A Cancer pain drug
02/19/2014CN103588663A Cancer pain drug
02/19/2014CN103588657A Method for producing phenylacetamide compound
02/18/2014US8653129 Combination therapy for skin disorders
02/18/2014CA2637630C Process for producing lactamide compounds, new lactamide compounds and formulations containing lactamide compounds
02/18/2014CA2619435C Process for the synthesis of mandipropamid and derivatives thereof
02/13/2014WO2014024989A1 Method for producing coumaramide
02/13/2014WO2014022879A1 Compounds for the treatment of mtor pathway related diseases
02/13/2014US20140046074 Substituted n-pentanamide compounds, preparation method and the use thereof
02/13/2014US20140045933 Methods and compositions for treating metabolic syndrome
02/13/2014US20140045931 Polyphenol proteasome inhibitors, synthesis, and methods of use
02/12/2014CN103570484A Asymmetric hydrogenation synthetic method of chiral aromatic amine compound with high steric hindrance
02/11/2014CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
02/06/2014US20140039060 Treatment of cell proliferative disorders
02/06/2014US20140038980 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
02/05/2014CN103555311A AM/NaAA/APO (acrylamide/sodium acrylate/N-allylphenoxyacetamide) ternary polymer flooding agent and synthesis method
02/05/2014CN103553958A Column [5] aromatic derivative modified by amido podand as well as preparation method and application thereof
02/05/2014CN103553953A Method for producing alpha,beta-unsaturated carboxylic acid-n,n-disubstituted amide and method for producing 3-alkoxycarboxylic acid-n,n-disubstituted amide
02/05/2014CN103553945A Alkoxy compounds for disease treatment
02/04/2014US8642653 Ketone compounds and compositions for cholesterol management and related uses
02/04/2014CA2358860C Dna-binding protein yb-1-containing collagen accumulation inhibitors
01/2014
01/30/2014WO2014016517A1 Fatty acid diamides comprising stearic hydroxyacids as organogelators
01/30/2014US20140031577 Haloalkylmethyleneoxyphenyl-Substituted Ketoenols
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 157